OPRA Pharmacology & Toxicology 2027: Syllabus & MCQs
Pharmacology and Toxicology accounts for approximately 15% of the OPRA exam syllabus, making it an important subject for overseas-qualified pharmacists preparing for the Australian Pharmacy Council (APC) examination.
For candidates preparing for the OPRA exam in 2027, this subject requires a clear understanding of drug mechanisms, receptor interactions, adverse drug reactions, drug interactions and the toxic effects of medicines.
Many pharmacy graduates are familiar with drug classifications but find it challenging to apply pharmacological principles to examination-style questions. Understanding why a medicine produces a particular effect is often more useful than memorising isolated drug names.
This guide explains the OPRA Pharmacology and Toxicology syllabus for 2027, important topics, preparation strategies, original practice MCQs with explanations and frequently asked questions.
What Is Pharmacology and Toxicology in the OPRA Exam?
Pharmacology and Toxicology is one of the five official content areas assessed in the Overseas Pharmacist Readiness Assessment.
Pharmacology focuses on how medicines produce biological effects, including their mechanisms of action, receptor interactions, desired effects and adverse reactions.
Toxicology examines the harmful effects of drugs and chemicals, mechanisms of poisoning, recognition of toxicity and principles of its management.
According to the APC examination guide, this content area covers seven broad groups:
Effects of drugs on the body
Receptor theory and drug-receptor interactions
Mechanisms of action of different drug categories
Adverse drug reactions
Drug interactions
Drug toxicity, poisoning and antidotes
Factors influencing drug effects and toxicity
Candidates should understand the underlying scientific principles and how they relate to medicine safety.
OPRA Pharmacology and Toxicology Weightage in 2027
The OPRA examination consists of 120 multiple-choice questions completed in 150 minutes.
The official examination blueprint allocates questions across five content areas.
| OPRA syllabus subject | Approximate weightage |
|---|---|
| Therapeutics and Patient Care | 45% |
| Biomedical Sciences | 20% |
| Pharmacology and Toxicology | 15% |
| Pharmacokinetics and Pharmacodynamics | 10% |
| Medicinal Chemistry and Biopharmaceutics | 10% |
| Total | 100% |
Although Pharmacology and Toxicology represents approximately 15% of the examination blueprint, candidates should not assume that every sitting contains exactly 18 scored questions from this area.
APC includes scored and unscored questions, and the content distribution follows its published examination specifications.
There is no separate passing requirement for Pharmacology and Toxicology. The final examination result depends on overall performance.
For a complete subject breakdown, read our OPRA Exam Syllabus and Subject Weightage Guide.
Important Topics in the OPRA Pharmacology and Toxicology Syllabus
Understanding the official topic groups can help candidates organise their revision effectively.
| Syllabus area | Important concepts |
|---|---|
| Drug effects | Dose-response relationships, agonists, antagonists and enzyme effects |
| Receptor theory | Drug-receptor binding, efficacy, potency and desensitisation |
| Mechanisms of action | Cardiovascular, CNS, anticoagulant, antihypertensive and anticancer medicines |
| Adverse reactions | Side effects, toxicity and adverse drug reaction mechanisms |
| Drug interactions | Enzyme induction, inhibition and pharmacodynamic interactions |
| Toxicology | Poisoning, overdose, mechanisms of toxicity and antidotes |
| Modifying factors | Genetics, age, pregnancy, kidney function and liver disease |
These are study-oriented examples from the published content area, not predictions about individual examination questions.
1. Drug Mechanisms of Action
A drug's mechanism of action describes how it produces a biological effect.
Understanding mechanisms helps explain therapeutic actions, adverse effects and interactions.
For example, beta-adrenoceptor antagonists reduce the actions of catecholamines at beta receptors.
Many beta blockers decrease heart rate and cardiac contractility through effects involving cardiac beta-1 receptors.
Similarly, angiotensin-converting enzyme (ACE) inhibitors reduce the formation of angiotensin II and influence blood pressure regulation.
Candidates should revise major drug categories and understand the relationship between the mechanism and the physiological response.
Important drug groups to review include:
Antihypertensive medicines
Anticoagulants and antiplatelet medicines
Drugs affecting the central nervous system
Medicines used in cardiovascular disorders
Lipid-lowering agents
Anticancer medicines
Analgesics and anti-inflammatory medicines
Focus on mechanism, receptor targets, important effects and safety considerations.
2. Receptor Theory: Agonists and Antagonists
Receptor theory is explicitly included in the OPRA Pharmacology and Toxicology syllabus.
A receptor is a biological target through which many medicines produce their effects.
Candidates should understand the differences between full agonists, partial agonists and antagonists.
| Concept | Meaning |
|---|---|
| Full agonist | Produces the maximum response available in a particular receptor system |
| Partial agonist | Produces a lower maximum response than a full agonist in the same system |
| Competitive antagonist | Competes with an agonist for receptor binding |
| Non-competitive antagonism | Reduces receptor-mediated response through mechanisms that cannot necessarily be overcome by increasing agonist concentration |
| Potency | Amount or concentration required to produce a specified effect |
| Efficacy | Ability to produce a biological response |
For example, a reversible competitive antagonist commonly shifts an agonist concentration-response curve to the right without reducing its maximum response, assuming sufficient agonist can overcome the antagonism.
Candidates should also revise receptor desensitisation, supersensitivity and dose-response relationships.
3. Adverse Drug Reactions
Adverse drug reactions (ADRs) are harmful or unintended responses associated with medicine use.
Understanding their causes and mechanisms is important for medicine safety.
A commonly taught classification distinguishes:
Type A reactions: Generally predictable from a medicine's known pharmacological action and often dose-related.
Type B reactions: Usually less predictable and not simply explained by the medicine's expected dose-dependent pharmacology.
For example, excessive anticoagulant activity can increase bleeding risk, while immune-mediated hypersensitivity reactions involve different mechanisms.
Candidates should understand how adverse reactions can arise from pharmacological effects, patient susceptibility and medicine interactions.
4. Drug–Drug Interactions
Drug interactions can change the effects or safety of medicines.
They may involve pharmacokinetic mechanisms, such as altered metabolism, or pharmacodynamic mechanisms, such as additive effects on the same physiological system.
Pharmacokinetic interaction example
An enzyme inhibitor may reduce the metabolism of a medicine and increase its concentration when that metabolic pathway is important for its elimination.
An enzyme inducer may increase metabolism and reduce exposure to certain active medicines.
However, the effects depend on the drug, its metabolites and the pathways involved.
Pharmacodynamic interaction example
Combining medicines that impair haemostasis can increase bleeding risk.
Candidates should understand the mechanisms of interactions rather than simply memorising long lists of interacting drugs.
5. Toxicology and Drug Overdose
Toxicology focuses on the harmful biological effects of drugs, chemicals and other substances.
The OPRA syllabus includes the mechanisms of toxicity, signs and symptoms of poisoning, antidotes and general management principles.
Important examples for educational revision include:
| Substance or drug | Toxicological concept |
|---|---|
| Paracetamol | Toxic metabolites and liver injury in overdose |
| Opioids | Respiratory depression and opioid receptor effects |
| Organophosphates | Acetylcholinesterase inhibition and cholinergic toxicity |
| Digoxin | Cardiac glycoside toxicity and abnormal cardiac rhythms |
| Iron | Systemic toxicity in significant overdose |
| Benzodiazepines | CNS depression, especially with other depressants |
Candidates should understand the relationship between the toxic mechanism and the clinical manifestations.
Certain poisonings have specific antidotes. For example, naloxone reverses opioid receptor-mediated toxicity, while N-acetylcysteine is used in paracetamol poisoning.
The appropriate management of an actual poisoning requires urgent clinical assessment and should not be based on examination notes.
6. Factors That Influence Drug Effects
Drug responses can vary between patients because of physiological, genetic and disease-related factors.
Important examples include:
Age: Drug handling and sensitivity can differ between children, adults and older people.
Kidney function: Reduced renal elimination may increase exposure to some medicines and their metabolites.
Liver function: Hepatic disease can alter metabolism and influence medicine exposure.
Pregnancy: Physiological changes may affect drug distribution, metabolism and elimination.
Genetics: Differences in drug-metabolising enzymes or pharmacological targets can influence effectiveness and toxicity.
These factors connect pharmacology with pharmacokinetics and therapeutics.
OPRA Pharmacology and Toxicology Practice MCQs With Answers
The following questions are original educational examples for pharmaceutical science revision. They are not official APC questions or recalled examination content.
Question 1: Receptor Pharmacology
A reversible competitive antagonist is added to a system containing a full agonist. What is the typical effect on the agonist concentration-response curve?
A. A leftward shift with increased potency
B. A rightward shift without changing maximum response
C. Complete elimination of all receptor activity
D. An increase in maximum agonist efficacy
Correct answer: B. A rightward shift without changing maximum response
Explanation: A reversible competitive antagonist generally increases the concentration of agonist needed to produce a given response. If sufficiently high agonist concentrations can overcome the antagonism, the maximum achievable response is preserved.
Question 2: Partial Agonists
Which statement BEST describes a partial agonist?
A. It produces no receptor activation
B. It always produces the same maximum response as a full agonist
C. It activates receptors but produces a lower maximum response than a full agonist in the same system
D. It permanently destroys receptors
Correct answer: C. It activates receptors but produces a lower maximum response than a full agonist in the same system
Explanation: Partial agonists have receptor efficacy but produce a lower maximal response than full agonists under comparable conditions.
Question 3: Drug Metabolism
An enzyme inhibitor reduces the metabolism of an active drug that is primarily cleared through the inhibited pathway.
What is the MOST likely effect?
A. Increased drug clearance
B. Reduced plasma drug concentration
C. Increased plasma drug concentration
D. Complete prevention of drug absorption
Correct answer: C. Increased plasma drug concentration
Explanation: Inhibition of an important metabolic pathway can reduce clearance and increase exposure to the active drug. Actual effects depend on the drug and relevant metabolic pathways.
Question 4: Cardiovascular Pharmacology
Which mechanism BEST explains the reduction in heart rate produced by a beta-1 adrenoceptor antagonist?
A. Activation of cardiac beta-1 receptors
B. Blockade of cardiac beta-1 receptors
C. Increased release of noradrenaline from sympathetic nerve terminals
D. Direct activation of muscarinic receptors
Correct answer: B. Blockade of cardiac beta-1 receptors
Explanation: Beta-1 receptor antagonism reduces sympathetic stimulation of the heart, which can decrease heart rate and contractility.
Question 5: Drug Interactions
A patient taking warfarin begins regularly using an oral non-steroidal anti-inflammatory drug (NSAID).
Which complication is particularly concerning?
A. Reduced bleeding risk
B. Increased bleeding risk
C. Increased vitamin K production
D. Complete loss of anticoagulant activity
Correct answer: B. Increased bleeding risk
Explanation: NSAIDs can increase bleeding risk through effects on gastrointestinal mucosa and platelet function, adding to the anticoagulant-associated risk.
Question 6: Opioid Toxicity
Which medicine is used to reverse opioid-induced respiratory depression in an emergency?
A. Naloxone
B. Atropine
C. N-acetylcysteine
D. Protamine sulfate
Correct answer: A. Naloxone
Explanation: Naloxone is an opioid receptor antagonist used to reverse opioid-mediated toxicity, including respiratory depression. Its effects may be shorter than those of the opioid involved, so emergency monitoring remains important.
Question 7: Paracetamol Poisoning
Which medicine is commonly used as an antidote in paracetamol overdose?
A. Vitamin K
B. Flumazenil
C. N-acetylcysteine
D. Calcium gluconate
Correct answer: C. N-acetylcysteine
Explanation: N-acetylcysteine helps restore glutathione availability and supports detoxification of the reactive metabolite associated with paracetamol-induced liver injury.
Question 8: Patient Factors
A medicine is predominantly eliminated unchanged by the kidneys.
What may occur when a patient develops substantially reduced renal function?
A. Renal clearance always increases
B. Drug elimination may decrease and exposure may increase
C. The medicine becomes completely inactive
D. Drug absorption always stops
Correct answer: B. Drug elimination may decrease and exposure may increase
Explanation: Impaired kidney function can reduce the elimination of renally cleared medicines, increasing exposure and potentially increasing toxicity risk.
How to Prepare for OPRA Pharmacology and Toxicology in 2027
A structured preparation strategy can make this content area easier to revise.
Start With Drug Classification and Mechanisms
Create a comparison chart showing major drug classes, biological targets, mechanisms and important adverse effects.
Understand Receptor Theory
Revise agonists, partial agonists, competitive antagonists, dose-response curves, potency and efficacy.
Practise interpreting conceptual questions rather than relying only on memorised definitions.
Connect Drug Mechanisms With Adverse Effects
For every major drug group, ask why an adverse reaction might occur.
Understanding the mechanism often makes the reaction easier to remember.
Revise Common Drug Interactions
Focus on the scientific principles of enzyme induction, enzyme inhibition and additive pharmacodynamic effects.
Include Toxicology Practice
Review mechanisms of poisoning, relevant clinical features and general antidote principles using reliable reference materials.
Practise Mixed MCQs
Use a combination of direct knowledge questions and applied scenarios.
After every practice session, review incorrect answers and identify recurring weak areas.
Seven-Day OPRA Pharmacology Revision Timetable
| Day | Topics to revise |
|---|---|
| Day 1 | Drug mechanisms and receptor theory |
| Day 2 | Cardiovascular pharmacology |
| Day 3 | CNS pharmacology |
| Day 4 | Adverse drug reactions and drug interactions |
| Day 5 | Toxicology and antidote principles |
| Day 6 | Factors affecting pharmacological responses |
| Day 7 | Mixed MCQs, revision and error analysis |
This is a suggested revision schedule, not an official APC preparation requirement.
Common Mistakes to Avoid
Memorising drug names without understanding mechanisms: Learn how and why a drug produces an effect.
Confusing potency with efficacy: Understand the difference between the amount needed for an effect and the maximum response produced.
Ignoring drug interactions: Both pharmacokinetic and pharmacodynamic mechanisms matter.
Studying toxicology only through antidote tables: Understand the mechanism of poisoning and its physiological effects.
Neglecting other subjects: Pharmacology and Toxicology represents 15% of the blueprint, but candidates must prepare across all five OPRA content areas.
Conclusion
Preparing for OPRA Pharmacology and Toxicology in 2027 requires more than remembering drug classifications.
Candidates should understand receptor interactions, pharmacological mechanisms, adverse reactions, drug interactions, toxicological principles and patient-specific factors affecting drug responses.
With approximately 15% of the official examination blueprint allocated to this area, Pharmacology and Toxicology deserves regular attention in your preparation timetable.
A concept-based approach combined with original practice questions can help strengthen your pharmaceutical knowledge and improve familiarity with examination-style problems.
Start with the official syllabus, identify your weaker topics and revise them consistently.
Free OPRA Preparation Resources
Need help organising your OPRA preparation? Request free OPRA preparation guidance through the enquiry form on opraexam.in.
The guidance service is independent of the official APC assessment process.
Official References
Disclaimer: opraexam.in is an independent educational resource and is not affiliated with or endorsed by the Australian Pharmacy Council. All practice questions are independently created educational examples and are not official APC examination questions. Clinical examples are intended for learning purposes and do not replace professional medical or toxicology advice.
Frequently Asked Questions
Common questions about OPRA Pharmacology & Toxicology 2027: Syllabus & MCQs.
What is the weightage of Pharmacology and Toxicology in OPRA?
Pharmacology and Toxicology accounts for approximately 15% of the official OPRA examination blueprint.
What topics are included in OPRA Pharmacology?
Topics include drug mechanisms, receptor theory, dose-response relationships, adverse drug reactions, drug interactions and factors influencing medicine effects.
Is toxicology included in the OPRA exam?
Yes. The syllabus includes toxic effects of drugs and chemicals, mechanisms of poisoning, recognition of toxicity and antidote principles.
Are drug interactions important for OPRA?
Yes. Candidates should understand both pharmacokinetic and pharmacodynamic interactions and their effects on drug safety.
Is there a separate passing score for Pharmacology and Toxicology?
No. APC determines the examination outcome using overall performance rather than individual passing marks for each content area.
How can I prepare for OPRA pharmacology questions?
Revise drug classes and mechanisms, strengthen receptor theory, practise adverse reaction and interaction questions, and review toxicology concepts using suitable educational resources.
Should I study Pharmacology before Therapeutics?
Understanding pharmacological mechanisms can make Therapeutics and Patient Care easier to study. However, candidates should integrate the subjects during preparation rather than treating them as completely unrelated areas.